Charles Schwab’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.7M | Buy |
1,212,407
+24,679
| +2% | +$238K | ﹤0.01% | 1892 |
|
|
2026
Q1 | $8.81M | Sell |
1,187,728
-29,424
| -2% | -$310K | ﹤0.01% | 2166 |
|
|
2025
Q4 | $14.3M | Buy |
1,217,152
+84,577
| +7% | +$912K | ﹤0.01% | 1952 |
|
|
2025
Q3 | $8.74M | Sell |
1,132,575
-55,027
| -5% | -$385K | ﹤0.01% | 2173 |
|
|
2025
Q2 | $8.68M | Buy |
1,187,602
+60,706
| +5% | +$490K | ﹤0.01% | 2087 |
|
|
2025
Q1 | $10.7M | Sell |
1,126,896
-34,456
| -3% | -$430K | ﹤0.01% | 1922 |
|
|
2024
Q4 | $19.1M | Buy |
1,161,352
+26,701
| +2% | +$415K | ﹤0.01% | 1729 |
|
|
2024
Q3 | $16.7M | Buy |
1,134,651
+57,677
| +5% | +$902K | ﹤0.01% | 1788 |
|
|
2024
Q2 | $14.9M | Sell |
1,076,974
-843
| -0.1% | -$12K | ﹤0.01% | 1837 |
|
|
2024
Q1 | $16.9M | Buy |
1,077,817
+31,252
| +3% | +$483K | ﹤0.01% | 1707 |
|
|
2023
Q4 | $16.9M | Buy |
1,046,565
+41,794
| +4% | +$684K | ﹤0.01% | 1688 |
|
|
2023
Q3 | $12.4M | Buy |
1,004,771
+16,451
| +2% | +$245K | ﹤0.01% | 1801 |
|
|
2023
Q2 | $15.9M | Buy |
988,320
+16,144
| +2% | +$266K | ﹤0.01% | 1652 |
|
|
2023
Q1 | $16.9M | Sell |
972,176
-3,885
| -0.4% | -$55.3K | 0.01% | 1594 |
|
|
2022
Q4 | $9.02M | Buy |
976,061
+30,231
| +3% | +$282K | ﹤0.01% | 1920 |
|
|
2022
Q3 | $8.14M | Buy |
945,830
+12,583
| +1% | +$125K | ﹤0.01% | 1952 |
|
|
2022
Q2 | $7.61M | Buy |
933,247
+16,064
| +2% | +$153K | ﹤0.01% | 1980 |
|
|
2022
Q1 | $11.1M | Buy |
917,183
+20,596
| +2% | +$433K | ﹤0.01% | 1892 |
|
|
2021
Q4 | $30.6M | Buy |
896,587
+18,538
| +2% | +$726K | 0.01% | 1248 |
|
|
2021
Q3 | $42.4M | Buy |
878,049
+31,631
| +4% | +$1.46M | 0.01% | 990 |
|
|
2021
Q2 | $38.2M | Buy |
846,418
+25,228
| +3% | +$1.12M | 0.01% | 1067 |
|
|
2021
Q1 | $39.6M | Buy |
821,190
+51,651
| +7% | +$2.69M | 0.01% | 985 |
|
|
2020
Q4 | $41.4M | Sell |
769,539
-15,139
| -2% | -$684K | 0.02% | 892 |
|
|
2020
Q3 | $28.9M | Sell |
784,678
-8,027
| -1% | -$298K | 0.01% | 965 |
|
|
2020
Q2 | $24.6M | Buy |
792,705
+98,047
| +14% | +$2.72M | 0.01% | 1035 |
|
|
2020
Q1 | $19.2M | Buy |
694,658
+12,121
| +2% | +$363K | 0.01% | 1047 |
|
|
2019
Q4 | $20M | Buy |
682,537
+15,873
| +2% | +$378K | 0.01% | 1215 |
|
|
2019
Q3 | $12.7M | Buy |
666,664
+99,910
| +18% | +$2.34M | 0.01% | 1446 |
|
|
2019
Q2 | $12.4M | Buy |
566,754
+52,594
| +10% | +$1.15M | 0.01% | 1456 |
|
|
2019
Q1 | $10.5M | Buy |
514,160
+65,986
| +15% | +$1.15M | 0.01% | 1555 |
|
|
2018
Q4 | $5.65M | Buy |
448,174
+67,066
| +18% | +$999K | ﹤0.01% | 1843 |
|
|
2018
Q3 | $5.85M | Buy |
381,108
+82,066
| +27% | +$1.13M | ﹤0.01% | 1963 |
|
|
2018
Q2 | $3.92M | Sell |
299,042
-6,953
| -2% | -$76.5K | ﹤0.01% | 2129 |
|
|
2018
Q1 | $2.5M | Buy |
305,995
+8,949
| +3% | +$72.5K | ﹤0.01% | 2248 |
|
|
2017
Q4 | $2.63M | Buy |
297,046
+86,006
| +41% | +$793K | ﹤0.01% | 2210 |
|
|
2017
Q3 | $2.35M | Buy |
211,040
+11,386
| +6% | +$111K | ﹤0.01% | 2233 |
|
|
2017
Q2 | $1.79M | Buy |
199,654
+1,235
| +0.6% | +$9.8K | ﹤0.01% | 2255 |
|
|
2017
Q1 | $1.57M | Buy |
198,419
+11,115
| +6% | +$90.5K | ﹤0.01% | 2280 |
|
|
2016
Q4 | $1.61M | Buy |
187,304
+10,010
| +6% | +$85.7K | ﹤0.01% | 2264 |
|
|
2016
Q3 | $1.46M | Buy |
177,294
+87,406
| +97% | +$733K | ﹤0.01% | 2280 |
|
|
2016
Q2 | $723K | Hold |
89,888
| – | – | ﹤0.01% | 2455 |
|
|
2016
Q1 | $606K | Hold |
89,888
| – | – | ﹤0.01% | 2505 |
|
|
2015
Q4 | $708K | Hold |
89,888
| – | – | ﹤0.01% | 2500 |
|
|
2015
Q3 | $516K | Buy |
89,888
+20,400
| +29% | +$126K | ﹤0.01% | 2613 |
|
|
2015
Q2 | $376K | Buy |
+69,488
| New | +$358K | ﹤0.01% | 2788 |
|
|
2014
Q2 | – | Sell |
-46,900
| Closed | -$163K | – | 3121 |
|
|
2014
Q1 | $163K | Hold |
46,900
| – | – | ﹤0.01% | 2993 |
|
|
2013
Q4 | $170K | Hold |
46,900
| – | – | ﹤0.01% | 2991 |
|
|
2013
Q3 | $143K | Hold |
46,900
| – | – | ﹤0.01% | 2999 |
|
|
2013
Q2 | $187K | Buy |
+46,900
| New | +$179K | ﹤0.01% | 2924 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Charles Schwab's NEO Position: Q2 2026 in Review
Charles Schwab increased its NeoGenomics (NEO) stake by 2.1% in Q2 2026, buying an estimated $238K and bringing the position to 1,212,407 shares worth $17.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1892.
Charles Schwab first reported a position in NEO in Q2 2013 and has held it in 49 quarters since. The position peaked at $42.4M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Charles Schwab held 1,212,407 shares of NeoGenomics worth $17.7M as of Q2 2026.
- Charles Schwab bought 24,679 NeoGenomics shares in Q2 2026, an estimated $238K.
- NeoGenomics made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1892 holding.
- Charles Schwab first reported a position in NeoGenomics in Q2 2013 and has held it in 49 quarters since.
- Charles Schwab's NeoGenomics position peaked at $42.4M in Q3 2021.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.